Haleon (HLN) Stock Chart - Revenue & Earnings | Quarter Chart
Revenue by Product
Revenue by Geography
Revenue, Gross Profit, Operating and Net Income
Margin (%)
Operating Expenses
EBITDA
EPS
Revenue Variation (%)
Income Variation (%)
Revenue YoY Variation (%)
Income YoY Variation (%)
Price-to-Earning Ratio
Income Breakdown
Per Share Metrics
Expense Ratios
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt Ratio
Current Ratio
Quick Ratio
Cash & Equivalents
Total Assets
Total Liabilities
Shareholders Equity
Asset Composition
Debt Structure
Haleon (HLN) quarterly earnings & revenue
Haleon (HLN) reported revenue of $7.41B for Q4 2025, up 98.4% year-over-year, with net income of $1.15B and diluted EPS of $0.26.
Over the last four reported quarters, Haleon generated $25.89B in revenue and $3.73B in net income.
Haleon's next earnings report is scheduled for July 30, 2026 before market open; analysts estimate EPS of $0.27.
Haleon quarterly results
| Fiscal quarter | Revenue | Revenue YoY | Net income | EPS (diluted) |
|---|---|---|---|---|
| Q4 2025 | $7.41B | +98.4% | $1.15B | $0.26 |
| Q2 2025 | $7.36B | -3.8% | $1.08B | $0.24 |
| Q1 2025 | $3.68B | -6.1% | $541.26M | $0.12 |
| Q4 2024 | $7.44B | -0.4% | $961.65M | $0.21 |
| Q3 2024 | $3.73B | — | $651.39M | $0.15 |
| Q2 2024 | $7.65B | -0.8% | $975.08M | $0.21 |
| Q1 2024 | $3.92B | — | $568.12M | $0.12 |
| Q4 2023 | $7.47B | +92.4% | $486.19M | $0.11 |
Haleon (HLN) — frequently asked questions
When does Haleon (HLN) report earnings next?
Haleon is expected to report earnings on July 30, 2026 before market open. Analysts estimate EPS of $0.27.
What was HLN's revenue last quarter?
Haleon reported revenue of $7.41B in Q4 2025, up 98.4% from the same quarter a year earlier.
What was HLN's EPS last quarter?
Haleon reported diluted EPS of $0.26 in Q4 2025.
Is Haleon profitable?
Haleon is currently profitable, with $3.73B in net income over the last four reported quarters.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Merck (MRK) · Roche (ROG.SW)